CubeSmart vs Sabra Health Care REIT
CUBE and SBRA side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CUBE and SBRA compare
CubeSmart is the larger company, worth 1.9 times as much as Sabra Health Care REIT ($9.6B against $5.0B).
On earnings, CubeSmart is cheaper: it trades at 30.1× trailing earnings, against 75.9× for Sabra Health Care REIT.
Sabra Health Care REIT grew revenue faster over the last twelve months (17.3% versus 5.0% for CubeSmart).
Both pay dividends: CubeSmart yields 5.0% and Sabra Health Care REIT 6.1%.
CubeSmart scores higher on the StockData Score (10 against 7 for Sabra Health Care REIT), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CUBE | SBRA |
|---|---|---|
| Size and price | ||
| Market cap | $9.6B | $5.0B |
| Share price | $42.74 | $19.74 |
| Change, 1 year | 6.6% | 14.6% |
| Change, 5 years | −20.2% | 32.2% |
| Beta (5Y) | 0.83 | 0.48 |
| Employees | 3,121 | 58 |
| StockData Score | ||
| Total score | 10 (better) | 7 |
| Valuation score | 0 | 0 |
| Growth score | 2 | 2 |
| Performance score | 0 | 2 (better) |
| Health score | 4 (better) | 0 |
| Dividend score | 4 (better) | 3 |
| Valuation | ||
| P/E | 30.1× (better) | 75.9× |
| P/S | 8.5× | 5.9× (better) |
| P/B | 3.6× | 1.8× (better) |
| EV/EBITDA | – | 12.5× |
| PEG | 7.14 | – |
| Fair value | $33.89 | $12.68 |
| Margin of safety | −26.1% (better) | −55.7% |
| Growth | ||
| Revenue growth (TTM) | 5.0% | 17.3% (better) |
| Revenue growth, 5Y average | 10.6% (better) | 5.3% |
| Net income growth (TTM) | – | −64.1% |
| EPS growth (TTM) | −16.0% (better) | −65.8% |
| EPS growth, 5Y average | 11.4% (better) | −0.91% |
| Profitability | ||
| Gross margin | 68.3% | – |
| Net margin | – | 7.6% |
| Return on equity | – | 2.4% |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Altman Z-score | 1.30 (better) | 1.25 |
| Piotroski F-score | – | 6 |
| Dividends and buybacks | ||
| Dividend yield | 5.0% | 6.1% (better) |
| Payout ratio | – | 455% |
| Years of dividend growth | 16 (better) | 0 |
| Dividend growth, 5Y average | 9.5% (better) | −2.3% |
| Buyback yield | 0.00% | – |
| Shareholder yield | 5.0% | 6.1% (better) |
| Ownership | ||
| Held by institutions | 103% | 102% |
| Held by insiders | 0.88% | 1.9% |
| Insider net buying, 12 months | −$7.3M | −$4.5M (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 3.9% | 7.9% |
Go deeper
- CUBE stock overview
- CUBE income statement
- CUBE valuation and score
- SBRA stock overview
- SBRA income statement
- SBRA valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.